p53 immunochemistry is an independent prognostic marker for outcome in conservatively treated prostate cancer.

Publication info: 
BJU Int. 2009 Jul; 104(1):20-4.
PMID: 
19239456
Publication date: 
July, 2009
Authors: 
Kudahetti S, Fisher G, Ambroisine L, Foster C, Reuter V, Eastham J, Møller H, Kattan MW, Cooper CS, Scardino P, Cuzick J, Berney DM
Publication type: